Home/Sama Therapeutics/Franz Hell, PhD
FH

Franz Hell, PhD

Chief AI Officer, Co-Founder

Sama Therapeutics

Therapeutic Areas

Sama Therapeutics Pipeline

DrugIndicationPhase
iMAGiNE™ Platform for Clinical Trial AccelerationCognitive, Affective, Interoceptive, Substance Use DisordersDevelopment
iMAGiNE™ Platform for Clinical Decision SupportMajor Depressive Disorder, ADHD, PTSD, OCD, SchizophreniaDevelopment
iMAGiNE™ for Direct-to-Consumer Brain Health TrackingWellness, Longevity, Psychedelic Medicine IntegrationDevelopment